Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration

  • 1.

    Nature News Round-up. Swine flu snipers, Alzheimer’s drug push and Google’s latest gaming bot. Nature 574 602–603 (2019).

  • 2.

    Rabinovici, G. D. et al. Association of amyloid positron emission tomography with subsequent change in clinical management among Medicare beneficiaries with mild cognitive impairment or dementia. J. Am. Med. Assoc. 94158, 1286–1294 (2019).

  • 3.

    Landau, S. M. et al. Comparing positron emission tomography imaging and cerebrospinal fluid measurements of β-amyloid. Ann. Neurol. 74, 826–836 (2013).

  • 4.

    Palmqvist, S. et al. Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease. Neurology 85, 1240–1249 (2015).

  • 5.

    Rabinovici, G. D. & Miller, B. L. Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs 24, 375–398 (2010).

  • 6.

    Bahia, V. S., Takada, L. T. & Deramecourt, V….

  • Read more…